cas 186407-74-9|| where to buy 4-bromo-1H-indazole

Nom du produit:4-bromo-1H-indazole

IUPAC Name:4-bromo-1H-indazole

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM100729-1000g	in stock	Ʃƅȋ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 186407-74-9 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:186407-74-9; Formule moléculaire:C7H5BrN2; Point de fusion:-; Code SMILES:BrC1=C2C=NNC2=CC=C1; Densité:1.77 g/cm3

: Numéro de catalogue:CM100729; Poids moléculaire:197.04; Point d'ébullition:333.8°C at 760 mmHg; N° Mdl:MFCD05664001; Stockage:Store at room temperature.

: Indazoles; Indazoles are a class of organic heterocyclic compounds, also known as 1,2-diazaindene and benzopyrazole. Indazole is a good bioisomer of phenol, which is more lipophilic than phenol and less prone to phase I and II metabolism. Indazole derivatives have a wide range of biological activities, and it has been confirmed that indazole compounds have anti-tumor, analgesic, anti-inflammatory and other drug activities. Anticancer is the most important application field of indazole drugs. Renal cell carcinoma, solid tumor, nausea and vomiting caused by chemotherapy and leukemia are the main indications of this structural backbone drug.

: Camizestrant; Recently, Evaluate Pharma released an analysis report on the trends in the biopharmaceutical industry in 2024. The report mentioned 10 potential key R&D pipelines, including the small molecule drug camizestrant. Camizestrant is a next-generation oral SERD and pure Erα antagonist that has demonstrated anti-cancer activity across a range of preclinical models, including in patients with ER-activating mutations.